Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (19068)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2019 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Joo MK, Park JJ, Chun HJ. Proton pump inhibitor: The dual role in gastric cancer. World J Gastroenterol 2019; 25(17): 2058-2070 [PMID: 31114133 DOI: 10.3748/wjg.v25.i17.2058] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i17/2058.htm |
| Number | Citing Articles |
| 1 |
Magdalena Dzikowiec, Dorota Pastuszak-Lewandoska. The uninvited guests of our microbiome: Helicobacter pylori and Epstein-Barr virus and their role in gastric cancerogenesis. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 611 doi: 10.2478/ahem-2021-0008
|
| 2 |
Man-Li Zhang, Yu-Xin Fan, Rui Meng, Wen-Ke Cai, Sun-Jun Yin, Tao Zhou, Yan-Hua Huang, Ping Wang, Fang-Fang Jiang, Mei Yang, Gong-Hao He. Proton Pump Inhibitors and Cancer Risk. American Journal of Clinical Oncology 2022; 45(11): 475 doi: 10.1097/COC.0000000000000949
|
| 3 |
Sun-Jin Boo. Are Proton Pump Inhibitors a Risk Factor for Gastric Cancer?. The Korean Journal of Gastroenterology 2022; 79(1): 49 doi: 10.4166/kjg.2022.004
|
| 4 |
Seung In Seo, Chan Hyuk Park, Seng Chan You, Jae Young Kim, Kyung Joo Lee, Jinseob Kim, Yerim Kim, Jong Jin Yoo, Won-Woo Seo, Hyung Seok Lee, Woon Geon Shin. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut 2021; 70(11): 2066 doi: 10.1136/gutjnl-2020-323845
|
| 5 |
Yifat Snir, Haim Leibovitzh, Yaara Leibovici‐Weissman, Alex Vilkin, Arnon D. Cohen, Tzippy Shochat, Yaron Niv, Iris Dotan, Ilan Feldhamer, Doron Boltin, Zohar Levi. Dose‐dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori‐positive patients. United European Gastroenterology Journal 2021; 9(3): 343 doi: 10.1177/2050640620951403
|
| 6 |
Fezzeh Elyasinia, Atefeh Tahmasebzadeh, Sahar Mirzaee, Soroush Rad, Ahmadreza Soroush, Khosrow Najjari, Mohammad Talebpour, Seyed Hossein Hajimirzaei, Maryam Abbasi. Gastric Cancer Patients’ Pathology and Diagnostic Laparoscopy Evaluation. Annals of Military and Health Sciences Research 2023; 21(4) doi: 10.5812/amh-143132
|
| 7 |
Decio CHINZON, Gerson DOMINGUES, Nivia TOSETTO, Marcos PERROTTI. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS. Arquivos de Gastroenterologia 2022; 59(2): 219 doi: 10.1590/s0004-2803.202202000-40
|
| 8 |
Fatemeh Rezaei, Masoud Alebouyeh, Seyedeh Zohre Mirbagheri, Amir Ebrahimi, Abbas Rahimi Foroushani, Ronak Bakhtiari. Transcriptional analysis of Helicobacter pylori cytotoxic-associated gene-pathogenicity island in response to different pH levels and proton pump inhibitor exposure. Indian Journal of Gastroenterology 2023; 42(5): 686 doi: 10.1007/s12664-023-01422-z
|
| 9 |
Bando TY, di Pace LS, Lapa M, Chehter EZ. Proton pump inhibitors: Are they safe?. Gastroenterology & Hepatology: Open Access 2022; 13(2): 34 doi: 10.15406/ghoa.2022.13.00492
|
| 10 |
Leon Fisher, Alexander Fisher, Paul N Smith. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). Journal of Clinical Medicine 2020; 9(10): 3253 doi: 10.3390/jcm9103253
|
| 11 |
Tahmina Nasrin Poly, Ming-Chin Lin, Shabbir Syed-Abdul, Chih-Wei Huang, Hsuan-Chia Yang, Yu-Chuan (Jack) Li. Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal. Cancers 2022; 14(13): 3052 doi: 10.3390/cancers14133052
|
| 12 |
Chengliang Zhou, Tanya M. Bisseling, Rachel S. van der Post, Annemarie Boleij. The influence of Helicobacter pylori, proton pump inhibitor, and obesity on the gastric microbiome in relation to gastric cancer development. Computational and Structural Biotechnology Journal 2024; 23: 186 doi: 10.1016/j.csbj.2023.11.053
|
| 13 |
Helge Waldum, Patricia Mjønes. Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells. Cancers 2020; 12(11): 3477 doi: 10.3390/cancers12113477
|
| 14 |
Hassan Akrami, Mohammad Reza Fattahi, Kiumars Mehdizadeh, Behrouz Moradi, Diba Borzabadi Farahani. The Effect of Pantoprazole on Tumor Growth and Apoptosis in Gastric Cancer Stem-Like Cells. Current Drug Therapy 2023; 18(1): 68 doi: 10.2174/1574885517666220815160530
|
| 15 |
Tien Tran, Seung-Kwon Myung, Thao Thi Trinh. Proton pump inhibitors and risk of gastrointestinal cancer: A meta‑analysis of cohort studies. Oncology Letters 2023; 27(1) doi: 10.3892/ol.2023.14161
|
| 16 |
Qinqin Xu, Xinyue Lan, Huimin Lin, Qiye Xi, Manchun Wang, Xiaolong Quan, Guangyu Yao, Zhiqiang Yu, Yongxia Wang, Meng Yu. Tumor microenvironment‐regulating nanomedicine design to fight multi‐drug resistant tumors. WIREs Nanomedicine and Nanobiotechnology 2023; 15(1) doi: 10.1002/wnan.1842
|
| 17 |
Seyed Reza Salarikia, Mohammad Kashkooli, Mohammad Javad Taghipour, Mahdi Malekpour, Manica Negahdaripour. Identification of hub pathways and drug candidates in gastric cancer through systems biology. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13052-0
|
| 18 |
Seung In Seo. Long Term Proton Pump Inhibitor Use and Gastric Cancer. Journal of Digestive Cancer Research 2022; 10(1): 9 doi: 10.52927/jdcr.2022.10.1.9
|
| 19 |
Qifang Sun, Chengzhi Yuan, Sainan Zhou, Jing Lu, Meiyan Zeng, Xiong Cai, Houpan Song. Helicobacter pylori infection: a dynamic process from diagnosis to treatment. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1257817
|
| 20 |
Jinke Huang, Yitian Wang, Peng Xu, Jiali Liu, Jinxin Ma, Yu Wang, Zhihong Liu, Mi Lv, Fengyun Wang, Xudong Tang, Talha Bin Emran. Molecular Mechanism of the Effect of Zhizhu Pill on Gastroesophageal Reflux Disease Based on Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/2996865
|
| 21 |
Rongrong Yang, Xixi Zhao, Wanqin Wu, Junling Shi. Potential of probiotics for use as functional foods in patients with non-infectious gastric ulcer. Trends in Food Science & Technology 2021; 111: 463 doi: 10.1016/j.tifs.2021.02.070
|
| 22 |
Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, Ka-Shing Cheung, Chung-Wah Siu. Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer. BMJ Open Gastroenterology 2021; 8(1): e000719 doi: 10.1136/bmjgast-2021-000719
|
| 23 |
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega. Potential proton pump inhibitor–related adverse effects. Annals of the New York Academy of Sciences 2020; 1481(1): 43 doi: 10.1111/nyas.14428
|
| 24 |
Ibrahim O. Sawaid, Abraham O. Samson. Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence. Journal of Clinical Medicine 2024; 13(7): 1970 doi: 10.3390/jcm13071970
|
| 25 |
Sadegh Fattahi, Novin Nikbakhsh, Hassan Taheri , Mohammad Ranaee, Haleh Akhavan-Niaki. RNA Sequencing of Early-Stage Gastric Adenocarcinoma Reveals Multiple Activated Pathways and Novel Long Non-Coding RNAs in Patient Tissue Samples. Reports of Biochemistry and Molecular Biology 2021; 9(4): 478 doi: 10.52547/rbmb.9.4.478
|
| 26 |
Rosângela Lucinda Rocha Monteiro, Maria Aparecida Marchesan Rodrigues Kobayasi, Marina Rachel de Araujo, Dafny Rocha Monteiro, Nelson Adami Andreollo. Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect?. Acta Cirúrgica Brasileira 2020; 35(9) doi: 10.1590/s0102-865020200090000004
|
| 27 |
Md. Zeyaullah, Abdullah M. AlShahrani, Irfan Ahmad, Giovanni Marasco. Association of Helicobacter pylori Infection and Host Cytokine Gene Polymorphism with Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8810620
|
| 28 |
K Landerholm. Time trends in incidence and survival of small intestinal cancer in Sweden. BJS Open 2021; 5(1) doi: 10.1093/bjsopen/zraa044
|
| 29 |
Qijin He, Limin Liu, Jingge Wei, Jiaying Jiang, Zheng Rong, Xin Chen, Jingwen Zhao, Kui Jiang. Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-00962-1
|
| 30 |
Rachel Gingold-Belfer, Nidal Issa, Doron Boltin, Yichayaou Beloosesky, Nira Koren-Morag, Joseph Meyerovitch, Eran Sharon, Noam Peleg, Hemda Schmilovitz-Weiss. Gastric cancer risk in the elderly is associated with omeprazole use and inversely associated with aspirin use. European Journal of Gastroenterology & Hepatology 2023; 35(9): 968 doi: 10.1097/MEG.0000000000002603
|
| 31 |
Huiqin Gao, Lunan Li, Ke Geng, Changzheng Teng, Yuanyuan Chen, Fei Chu, Yi Zhao. Use of proton pump inhibitors for the risk of gastric cancer. Medicine 2022; 101(49): e32228 doi: 10.1097/MD.0000000000032228
|